298 related articles for article (PubMed ID: 30158855)
1. Targeted Reactivation of
Haenfler JM; Skariah G; Rodriguez CM; Monteiro da Rocha A; Parent JM; Smith GD; Todd PK
Front Mol Neurosci; 2018; 11():282. PubMed ID: 30158855
[TBL] [Abstract][Full Text] [Related]
2. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
5. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
[TBL] [Abstract][Full Text] [Related]
6. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variability to medication management: an update on fragile X syndrome.
Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome.
Tabolacci E; Palumbo F; Nobile V; Neri G
Genes (Basel); 2016 Aug; 7(8):. PubMed ID: 27548224
[TBL] [Abstract][Full Text] [Related]
9. FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.
Roth M; Ronco L; Cadavid D; Durbin-Johnson B; Hagerman RJ; Tassone F
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679478
[TBL] [Abstract][Full Text] [Related]
10. The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.
Jalnapurkar I; Frazier JA; Roth M; Cochran DM; Foley A; Merk T; Venuti L; Ronco L; Raines S; Cadavid D
J Neurodev Disord; 2022 Dec; 14(1):57. PubMed ID: 36494616
[TBL] [Abstract][Full Text] [Related]
11. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.
Ludwig AL; Espinal GM; Pretto DI; Jamal AL; Arque G; Tassone F; Berman RF; Hagerman PJ
Hum Mol Genet; 2014 Jun; 23(12):3228-38. PubMed ID: 24463622
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Reactivation of the Silenced
Kumari D; Gazy I; Usdin K
Brain Sci; 2019 Feb; 9(2):. PubMed ID: 30759772
[TBL] [Abstract][Full Text] [Related]
13. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
14. A Genotype-Phenotype Study of High-Resolution
Budimirovic DB; Schlageter A; Filipovic-Sadic S; Protic DD; Bram E; Mahone EM; Nicholson K; Culp K; Javanmardi K; Kemppainen J; Hadd A; Sharp K; Adayev T; LaFauci G; Dobkin C; Zhou L; Brown WT; Berry-Kravis E; Kaufmann WE; Latham GJ
Brain Sci; 2020 Sep; 10(10):. PubMed ID: 33008014
[TBL] [Abstract][Full Text] [Related]
15. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
Gerhardt J
Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
[TBL] [Abstract][Full Text] [Related]
17. Unstable mutations in the FMR1 gene and the phenotypes.
Loesch D; Hagerman R
Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
[TBL] [Abstract][Full Text] [Related]
18. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome.
Todd PK; Oh SY; Krans A; Pandey UB; Di Prospero NA; Min KT; Taylor JP; Paulson HL
PLoS Genet; 2010 Dec; 6(12):e1001240. PubMed ID: 21170301
[TBL] [Abstract][Full Text] [Related]
20. Site-specific R-loops induce CGG repeat contraction and fragile X gene reactivation.
Lee HG; Imaichi S; Kraeutler E; Aguilar R; Lee YW; Sheridan SD; Lee JT
Cell; 2023 Jun; 186(12):2593-2609.e18. PubMed ID: 37209683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
